Today: 19 July 2026
First Majestic Silver stock rises premarket as silver hits two-week high; dividend date looms
23 February 2026
1 min read

First Majestic Silver stock rises premarket as silver hits two-week high; dividend date looms

New York, Feb 23, 2026, 08:44 EST — Premarket

  • AG tacked on roughly 1% ahead of the open, following Friday’s strong surge.
  • Silver gains, boosted by safe-haven bids as tariff uncertainty lingers
  • Traders are again eyeing the company’s Feb. 27 dividend record date.

First Majestic Silver Corp (AG) inched up roughly 1% to $27.82 in premarket action Monday. Shares finished Friday’s session at $27.55, having climbed 11.2% during the day.

This month, silver miners have swung sharply—essentially behaving as high-beta plays on the metal itself—reacting fast to even minimal moves in rates or shifts in risk appetite. Once mills are in motion, a jolt in bullion prices can drive revenue changes that outpace any adjustment on the cost side.

Spot silver climbed to its highest level in over two weeks, boosted as the dollar slipped after the U.S. Supreme Court struck down former President Donald Trump’s broad tariffs. The ruling also appeared to drive some safe-haven demand. “Concerns or confusion … over the outlook for tariffs” played a role, said independent analyst Ross Norman. Reuters

Other names were up in early trading too. Pan American Silver (PAAS) gained roughly 0.9%, Hecla Mining (HL) advanced 2%, and Coeur Mining (CDE) picked up around 1.1%.

First Majestic shares shot higher late last week after the company reported fourth-quarter revenue of $463.9 million and adjusted earnings of 30 cents per share. Silver output hit a record, coming in at roughly 4.2 million ounces for the quarter. The miner’s all-in sustaining cost clocked in at $23.48 per silver-equivalent ounce. Directors approved a quarterly dividend of $0.0083 per share for investors on record as of Feb. 27.

H.C. Wainwright analyst Heiko F. Ihle bumped his price target up to $30 from the previous $24.50, keeping a “buy” rating, GuruFocus reported in a summary of his note. GuruFocus

First Majestic runs mines across Mexico and the U.S.—San Dimas, Santa Elena, La Encantada among them. It also holds a 70% interest in the Cerro Los Gatos joint venture, according to LSEG data cited on Reuters.

Leverage cuts both ways here. Silver dropping, the dollar bouncing back, or even higher costs when prices are already up—any of those can knock miners fast. Margins usually take the first punch when something goes wrong at a specific company.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • SpaceX in Negotiations for Multibillion-Dollar AI Deal with U.S. Defense Department
    July 18, 2026, 7:49 PM EDT. SpaceX is negotiating to land a multibillion-dollar agreement with the U.S. Department of Defense to operate AI models on its data centers. The potential deal stands to support SpaceX's $1.6 trillion AI outlay following its purchase of xAI. Despite a $6.4 billion operating loss for xAI in 2025, the Pentagon contract could deliver critical revenue and strengthen SpaceX's bottom line. If finalized, the arrangement would position SpaceX among a small number of cloud firms supplying AI for Pentagon projects. The talks, which have not been finalized, highlight SpaceX's expanding presence in defense AI and its shift from focusing on rocket launches to targeting AI-centered expansion.
Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week
Previous Story

Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop